Priced for a smaller company: management is quietly telling investors the business has already outgrown what the numbers
The model's full reasoning — Q4 2022 call → NOThe question asks whether management conveys that outsiders are currently underweighting something the company has already done, and whether management points to at least one concrete, already-completed or already-operating piece of the business whose contribution is still largely ahead of reported results. Let me analyze the transcript for these elements. First, is there a recognition gap that management itself raises? Management would need to indicate that the way the company is currently seen, valued, measured, modeled, or asked about does not match what the company already is. Looking through the transcript, I see Jeff Gennette discussing the five growth vectors. He says things like "We're in the early innings of these growth factors" and discusses private brands, off-mall stores, marketplace, luxury, and personalization. For the private brands: "We started with an initial update of INC in mid-2022. Early results have been favorable with fourth quarter sales up 28% to last year." This is an already-operating thing with results. For off-mall stores: "We currently have 8 Market by Macy's and 2 Bloomie's... Looking at the 5 Market by Macy's and the 1 Bloomie's that have been open for over a year, fourth quarter comparable owned plus licensed sales increased by 8% and 12% respectively." These are already operating. For marketplace: "Since its launch last September, we had found that over 90% of our total marketplace customer base are Macy's Cross shoppers." Launched and operating. For luxury: "In 2022, both Bloomingdale's and Bluemercury achieved their highest annual sales volume in history." For personalization: "This year, we have run tests with tens of millions of Macy's customers... We are pleased with early learnings and we will continue to refine offers and communication." Now, does management convey that outsiders are underweighting something? Let me look for language about how the company is perceived or measured. Adrian Mitchell says: "We have achieved financial and operational stability while navigating the past 3 years of global uncertainty.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
PRPH · Q1 2023 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES The transcript shows management explicitly framing the current market view as mismatched with the company's actual position: "Anybody that's focused on us for earnings, you invested or are following the wrong company," "we're not an earnings story this year," and "focus less on revenues and earnings. This is a transition year." They repeatedly contrast this with the multi-billion-dollar assets already built and operating, whose contributions are still ramping or largely ahead. Concrete already-real items with meaningful payoff still ahead include: - The manufacturing facility (already at capacity, running nearly 100% YoY growth, with $25M revenue target for 2024 constrained only by capacity expansion this year; estimated $70M valuation next year plus $40M working capital and tens of millions in equipment). - Nebula Genomics (already generating >100% YoY revenue growth via direct-to-consumer sales; in-house whole-genome processing and B2B ramp expected in H2 202 3, particularly Q4, after validations complete in a couple of months).
KEY · Q3 2022 → YESThe question is: Does management convey that OUTSIDERS ARE CURRENTLY UNDERWEIGHTING SOMETHING THE COMPANY HAS ALREADY DONE — and does management answer that gap by pointing to at least one CONCRETE, A...YES Management repeatedly frames its interest-rate-risk positioning as something that “sets Key apart” and creates “unique and significant upside” that is not yet reflected in the market’s view of the company. Chris Gorman states that the $1.2 billion annualized benefit from re-pricing existing short-term Treasuries and swaps “ even in the event that rates remain at current levels” will arrive over the next two years, and Don Kimble confirms the same mechanics and timing. The $9 billion in short-term Treasuries and $26 billion in swaps are already on the balance sheet; the contribution is simply not yet in the reported results.
KIM · Q2 2018 → YESThe question is: Does management convey that outsiders are currently underweighting something the company has already done, and do they point to at least one concrete, already-completed or already-ope...YES Management explicitly frames the public-private pricing disconnect as a gap in how the company is valued versus its actual assets and execution. They point to the already-completed Toys "R" Us liquidation process (22 boxes resolved into OpCo and PropCo leases, with seven OpCo leases already signed and seven PropCo under 18-24 month resolution) as a concrete, already-real item whose rent contribution is still largely ahead in the reported results, with the 70-80 bps impact on occupancy and same-site NOI expected to be recaptured in Q3 and beyond.